We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.25B
AUM Growth
+$136M
Cap. Flow
+$60.6M
Cap. Flow %
4.87%
Top 10 Hldgs %
22.84%
Holding
2,021
New
430
Increased
368
Reduced
444
Closed
703

Sector Composition

Rank Sector Weight
1 Technology 16.16%
2 Communication Services 12.62%
3 Healthcare 9.79%
4 Consumer Discretionary 7.25%
5 Industrials 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTGT icon
1126
TechTarget
TTGT
$312M
$20K ﹤0.01%
1,423
-877
-38% -$11.4K
INOV
1127
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$20K ﹤0.01%
+1,317
New +$20.9K
ABEO icon
1128
Abeona Therapeutics
ABEO
$385M
$19K ﹤0.01%
48
-859
-95% -$355K
DPZ icon
1129
PUT
Domino's
DPZ
$12.1B
$19K ﹤0.01%
+100
New +$18.5K
GRC icon
1130
Gorman-Rupp
GRC
$2.27B
$19K ﹤0.01%
600
-1,026
-63% -$32.5K
LQDT icon
1131
Liquidity Services
LQDT
$1.17B
$19K ﹤0.01%
+3,876
New +$21.1K
OSIS icon
1132
OSI Systems
OSIS
$3.89B
$19K ﹤0.01%
300
-1,400
-82% -$118K
VSEC icon
1133
VSE Corp
VSEC
$5.99B
$19K ﹤0.01%
+384
New +$19.7K
XHE icon
1134
State Street SPDR S&P Health Care Equipment ETF
XHE
$160M
$19K ﹤0.01%
301
+71
+31% +$4.58K
AYR
1135
DELISTED
Aircastle Ltd
AYR
$19K ﹤0.01%
800
+200
+33% +$4.7K
COR icon
1136
PUT
Cencora
COR
$61.7B
$18K ﹤0.01%
+200
New +$16.5K
FXH icon
1137
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
$18K ﹤0.01%
257
+64
+33% +$4.37K
IONS icon
1138
Ionis Pharmaceuticals
IONS
$9.04B
$18K ﹤0.01%
350
-31,979
-99% -$1.75M
MCFT icon
1139
MasterCraft Boat Holdings
MCFT
$613M
$18K ﹤0.01%
+800
New +$18K
NH
1140
DELISTED
NantHealth, Inc
NH
$18K ﹤0.01%
+387
New +$20.5K
I
1141
DELISTED
INTELSAT S. A.
I
$18K ﹤0.01%
5,216
+3,370
+183% +$15K
RGC
1142
PUT
DELISTED
Regal Entertainment Group
RGC
$18K ﹤0.01%
+800
New +$14.7K
AVNW icon
1143
Aviat Networks
AVNW
$271M
$17K ﹤0.01%
2,240
-1,800
-45% -$14.1K
SSD icon
1144
Simpson Manufacturing
SSD
$8.13B
$17K ﹤0.01%
+300
New +$16.6K
ITCI
1145
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$17K ﹤0.01%
1,175
-587
-33% -$9.06K
CTXS
1146
DELISTED
Citrix Systems Inc
CTXS
$17K ﹤0.01%
+192
New +$16.3K
FAF icon
1147
First American
FAF
$7.68B
$16K ﹤0.01%
+290
New +$15.6K
LAB icon
1148
Standard BioTools
LAB
$310M
$16K ﹤0.01%
2,772
-2,823
-50% -$15.5K
VECO icon
1149
Veeco
VECO
$3.27B
$16K ﹤0.01%
+1,050
New +$18.1K
LSXMK
1150
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$16K ﹤0.01%
+525
New +$16.7K

Similar funds

Prelude Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Prelude Capital Management held 2,021 positions worth $1.25B, up 12% from $1.11B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Prelude Capital Management deployed $60.6M of net new capital in Q4 2017, opening 430 new positions and adding to 368 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 328,795 shares worth $11.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Western Digital, an estimated $7.02M trimmed.

  • Prelude Capital Management's largest Q4 2017 buy was Twenty-First Century Fox, Inc. Class B: 328,795 shares worth $11.2M.
  • Prelude Capital Management added most to NXP Semiconductors in Q4 2017, an estimated $28M increase.
  • Prelude Capital Management's biggest Q4 2017 reduction was Western Digital, cutting an estimated $7.02M.
  • Prelude Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $30M.
  • Prelude Capital Management's ten largest holdings make up 23% of its $1.25B portfolio in Q4 2017.
  • Prelude Capital Management opened 430 new positions and closed 703 in Q4 2017.
  • Prelude Capital Management's portfolio value rose 12% quarter-over-quarter to $1.25B.

Based on Prelude Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.